Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
Treatment with low-molecular-weight heparins is very common in clinical practice. Exceptionally, some patients develop hepatitis within a few days of starting treatment, and rapid discontinuation of the drug is decisive to avoid chronification.
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-11-01
|
Series: | Advances in Laboratory Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/almed-2021-0048 |
_version_ | 1797806257483022336 |
---|---|
author | Velasco de Cos Guillermo Sánchez-Molina Acosta Isabel Iturralde Ros Marta Maiztegi Azpitarte Ainhoa Moyano Martinez Ana |
author_facet | Velasco de Cos Guillermo Sánchez-Molina Acosta Isabel Iturralde Ros Marta Maiztegi Azpitarte Ainhoa Moyano Martinez Ana |
author_sort | Velasco de Cos Guillermo |
collection | DOAJ |
description | Treatment with low-molecular-weight heparins is very common in clinical practice. Exceptionally, some patients develop hepatitis within a few days of starting treatment, and rapid discontinuation of the drug is decisive to avoid chronification. |
first_indexed | 2024-03-13T06:04:32Z |
format | Article |
id | doaj.art-bb645636d4664aa0b283263ea44612bd |
institution | Directory Open Access Journal |
issn | 2628-491X |
language | English |
last_indexed | 2024-03-13T06:04:32Z |
publishDate | 2021-11-01 |
publisher | De Gruyter |
record_format | Article |
series | Advances in Laboratory Medicine |
spelling | doaj.art-bb645636d4664aa0b283263ea44612bd2023-06-12T06:17:16ZengDe GruyterAdvances in Laboratory Medicine2628-491X2021-11-012457557810.1515/almed-2021-0048Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatmentVelasco de Cos Guillermo0Sánchez-Molina Acosta Isabel1Iturralde Ros Marta2Maiztegi Azpitarte Ainhoa3Moyano Martinez Ana4Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, SpainHospital Comarcal de Laredo, Laredo, Cantabria, SpainHospital Universitario Marqués de Valdecilla, Santander, Cantabria, SpainHospital Universitario Marqués de Valdecilla, Santander, Cantabria, SpainHospital Universitario Marqués de Valdecilla, Santander, Cantabria, SpainTreatment with low-molecular-weight heparins is very common in clinical practice. Exceptionally, some patients develop hepatitis within a few days of starting treatment, and rapid discontinuation of the drug is decisive to avoid chronification.https://doi.org/10.1515/almed-2021-0048cholestasisenoxaparinhepatitistoxicitytransaminases |
spellingShingle | Velasco de Cos Guillermo Sánchez-Molina Acosta Isabel Iturralde Ros Marta Maiztegi Azpitarte Ainhoa Moyano Martinez Ana Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment Advances in Laboratory Medicine cholestasis enoxaparin hepatitis toxicity transaminases |
title | Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment |
title_full | Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment |
title_fullStr | Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment |
title_full_unstemmed | Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment |
title_short | Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment |
title_sort | hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment |
topic | cholestasis enoxaparin hepatitis toxicity transaminases |
url | https://doi.org/10.1515/almed-2021-0048 |
work_keys_str_mv | AT velascodecosguillermo hepatotoxicitywithcholestaticpatternsecondarytoenoxaparintreatment AT sanchezmolinaacostaisabel hepatotoxicitywithcholestaticpatternsecondarytoenoxaparintreatment AT iturralderosmarta hepatotoxicitywithcholestaticpatternsecondarytoenoxaparintreatment AT maiztegiazpitarteainhoa hepatotoxicitywithcholestaticpatternsecondarytoenoxaparintreatment AT moyanomartinezana hepatotoxicitywithcholestaticpatternsecondarytoenoxaparintreatment |